Pruritus in hiv-1 disease: Therapy with drugs which may modulate the pattern of immune dysregulation

Dermatology

Volumn 195, Issue 4, 1997, Pages 353-358

  Smith, K J ^c   Skelton, H G ^b   Yeager, J ^c   Lee, R B ^a   Wagner, K F ^d  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

Antihistamines; Antiprostaglandin; Phosphodiesterase inhibitor; Pruritus

Indexed keywords

ANTIHISTAMINIC AGENT; CYTOKINE; DOXEPIN; HYDROXYZINE; INDOMETACIN; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN INHIBITOR; STEROID;

ABDOMINAL PAIN; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DROWSINESS; DRY EYE; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIGESTION; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0031457181     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000245987     Document Type: Article

References (33)

1. Hoover WD Jr. Lang PG: Pruritus in HIV infection. J Am Acad Dermatol 1991:6: 1020-1021.
2. Smith KJ. Skelton HG, Yeager J. Lcdsky R. McCarthy W. Baxter D. Wagner KK Military Medical Consortium for the Advancement of Retroviral Research (MMCARR): Cutaneous findings in HIV-1-positive patients: A 42-month prospective study. J Am Acad Dermatol 1994:31:747-754.
3. Smith KJ. Wagner KF. Yeager J. Skelton HG. Ledsky R: Staphylococcus aureus carriage and HIV-1 disease: Association with increased mucocutaneous infections as well as deep soft tissue and sepsis, and a possible role in disease progression. Arch Dermatol 1994:130: 521-522.
4. Duvic M: Staphylococcal infections and the pruritus of AIDS-related complex. Arch Dermatol 1987:123:1599.
5. Ashack RJ. Frost ML. Norms AL: Papular pruritic eruption of Demodex folliculitis in patients w ith the acquired immunodeficiency syndrome. J Am Acad Dermatol 1988:18: 452-456.
6. Blauvelt A. Plot! RT. Spooner K. Stettin B. Davey RT. Turner ML: Eosinophilic folliculitis associated w ith AIDS responds well to permc-thrin. Arch Dermatol 1995:131:360-361.
7. Orkin M: Scabies in AIDS. Semin Dermatol 1993:12:9-14.
8. Clerici M, Shearer GM: AThl toTh2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993:14:107-111.
9. Romagnani S. Del Prete G. Ravina MA. An-nunziato F. De Carll M. Mazzctti M. Piccinni M-P. D'Elios MM. Parronchi P. Sampignaro S. Maggi E: Role of Thl/Th2 cytokines in HIV infection. Immunol Rev 1994:140:73-92.
10. Wright DN. Nelson RP. Ledford DK. Fernan-dez-Caldas E, Trudeau W. Lockey R: Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1990:85: 445-152.
11. Smith KJ. Skelton HG. Drabick JJ. McCarthy WF. Ledsky R. Wagner KF: Hypereosinophilia secondary to immunodysregulation in patients with HIV-1 disease. Arch Dermatol 1994:130: 119-121.
12. Paganelli R. Fanales-Belasio E. Scala E. Carmini D. Mczzarana L, Pinter E. Aiuti F: Serum eosinophil cationic protein (ECP) in human immunodeficiency virus infection. J Allergy Clin Immunol 1991:88:416-418.
13. Bentwich Z. Kalinkovich A. Weisman Z: Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995:16:187-191.
14. Dalgleish AG: The immune response to HIV: Potential for immunotherapy? Immunol Today 1995:16:356-358.
15. Haraguchi S. Good RA. Day NK: Immunosuppressive retroviral peptides cAMP and cytokine patterns. Immunol Today 1995:16: 595-602.
16. Ogasawara M. Cianciolo GJ. Snyderman R. Mitani M. Good RA. Day NK: Human IFN-gannna production is inhibited by a synthetic peptide homologous to retroviral envolope protein. J Immunol 1988:141:614-619.
17. Anatassiou ED. Paliogianni F. Balow JP. Ya-mada H, Boumpas DT: Prostaglandin E. and other cAMP-elevating agents modulate IL-2 and IL-12R alpha gene expression at multiple levels. J Immunol 1992:148:2845-2852.
18. Longe N. Zabay JM. Sempere JM. Navarro J. Fernandez-Cruz E: Altered production of PGE,. IL-1 p. and TNF-alpha by peripheral blood monocytes from HIV-positive individuals at early stages of HIV infection. J Acquir Immun Defic Syndr 1993:6:1017-1023.
19. Mitzel SB: cAMP and IL-1 signal transduction. Immunol Today 1990:11:390-391.
20. Fernandes-Cruz E, Gelpi E. Longo N. Gonzalez B. de la Marena MT. Montes MG. Rosello J. Ramis L, Suarez A. Fernandez A: Increased synthesis and production of prostaglandin E. by monocytes from drug addicts with AIDS. AIDS 1989:3:91-96.
21. Eng C. Gerstoft J. Mollcr S. Remig L: Interleukin-1 activity in AIDS. Scand J Immunol 1986;23:491-497.
22. Hamlin JM. Chan SC: Monocyle phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995:105:84S-88S.
23. Hofmann B. Nishanian P. Nguyen T, Liu M. Fahey JL: Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993:7:659-664.
24. Munoz E. Zubiaga E. Merrow AM. Sauter NP. Huber BT: Cholera toxin discriminates between T helper 1 and 2 cells in Tcell receptor-mediated activation: Role of cAMP in T cell proliferation. J Exp Med 1990:172:95-103.
25. Zabel P. Schade FU. Schlaak M: Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993:187:447-463.
26. Navarro J. Pizarro A. Fernandez-Cruz E. Fresno M, Munoz-Fernandez MA: Pentoxifylline preferentially inhibits interleukin-10 production by HIV-1-infected human T cells. AIDS 1994:8:1192-1194.
27. Dezube BJ: Pentoxifylline for the treatment of infection with human immunodeficiency virus. Clin Infect Dis 1994:18:285-287.
28. Dezube BJ. Lederman MM. Spritzler JG. Chapman B. Karvick JA. Flexner C, Dando S. Maltiacci MR. Aiders CM. Zhang L.: High-dose pentoxifylline in patients with AIDS: Inhibition of tumor necrosis factor production. J Infect Dis 1995:171:1628-1632.
29. Sathe SS. Sarai A. Tsigler D. Nedunchezian D: Pentoxifylline aggravates impairment in tumor necrosis factor-alpha secretion and increases mycobacterial load in macrophages from AIDS patients with disseminated Mycobacterium avium-inirucelliiUire complex infection. J Infect Dis 1994:170:484-487.
30. Stadler I. Chadha KC. Nakeeb S, Toumbis C, Butsch J. Matluir N. Munsehaucr F: Pentoxifylline and meclofenamic acid treatment reduces clinical manifestations in a murine model of AIDS. J Phamacol Exp Tiler 1994: 268:10-13.
31. Bourinbaiar AS. Lee-Huang S: The non-steroidal anti-inflammatory drug, indomethacin. as an inhibitor of HIV replication. FF.BS Lett 1995:20:85-89.
32. Cantabrana B. Perez V. Menendez L. Hidalgo A: Spasmolytic and calmodulin inhibitory effect of non-steroidal antiinflammatory drugs in vitro. Life Sci 1995:57:1333-1341.
33. Hahn KB. Kim WH, Lee SI, Kang JK. Park IS: Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimeti-dinc. ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. Scand J Gastroenterol 1995:30: 265-271.